DossierENTITY

Major drugmaker

Coverage of Major drugmaker in the Nexus archive.

Earliest in view: Jul 9 · 09:53 UTCMost recent: Jul 9 · 09:53 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 9 · 09:53 UTCMARKETWATCH
Major drugmaker loses $27 billion in market value after failed trial
A major drugmaker lost $27 billion in market value after a heart disease drug failed its Phase III trial, as announced by two companies on Thursday.